Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer
NCT03327064Phase 2Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2020
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 9cUAB30 in non-melanoma skin cancer (NMSC), sponsored by University of Alabama at Birmingham. Planned start Oct 2020; status: withdrawn.
02
Drugs
9cUAB30
03
Conditions
non-melanoma skin cancer (NMSC)
Beyond the preview
Go deeper on NCT03327064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03327064.